NSAID-related CV risks not defined by COX-2 selectivity alone

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1622, 2008-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CV disorder risks extend beyond COX-2-selectivity of NSAIDs

By  

Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Increased COX-2 selectivity of NSAIDs appears to be associated with increased cardiovascular (CV) risks

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Understanding the COX-2/NSAID Dilemma

By Roth Sanford H.  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 1915-1917

Adis International

Access to resources Recommend Favorite

NSAID-related GI disorders costly in Canada's elderly

By  

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost of NSAID-related GI complications varies globally

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite